SEC Form 4 · accession 0001179110-15-006955
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Lambert
Officer — Executive Vice President
Period of report
May 1, 2015
Accepted (ET)
May 4, 2015 · 9:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 1, 2015 | M | 10,000 | $5.35 | A | 116,857 | D | |
| Common StockF1 | May 1, 2015 | S | 10,000 | $8.3184 | D | 106,857 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $5.35 | May 1, 2015 | M | 10,000 | D | Jun 9, 2006 | Jun 9, 2015 | Common Stock | 10,000 | 15,000 | D |
Explanation of responses
- F1Weighted average price of shares sold.
- F2The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on February 20, 2015.
- F3Exercisable as to 11,667 shares commencing on June 9, 2006, 11,667 shares commencing on June 9, 2007, and 11,666 shares commencing on June 9, 2008.